Document is current
Any future updates will be listed below
-
Authors
Gee, Peter http://orcid.org/0000-0002-2481-5103
Lung, Mandy S. Y. http://orcid.org/0000-0001-6343-8294
Okuzaki, Yuya http://orcid.org/0000-0002-7212-4366
Sasakawa, Noriko
Iguchi, Takahiro http://orcid.org/0000-0003-2030-1145
Makita, Yukimasa http://orcid.org/0000-0002-9566-8286
Hozumi, Hiroyuki
Miura, Yasutomo
Yang, Lucy F.
Iwasaki, Mio http://orcid.org/0000-0003-2085-732X
Wang, Xiou H. http://orcid.org/0000-0003-3569-3073
Waller, Matthew A. http://orcid.org/0000-0001-5748-9159
Shirai, Nanako
Abe, Yasuko O. http://orcid.org/0000-0002-2356-8649
Fujita, Yoko http://orcid.org/0000-0002-2411-5473
Watanabe, Kei http://orcid.org/0000-0002-3927-9278
Kagita, Akihiro
Iwabuchi, Kumiko A. http://orcid.org/0000-0003-4671-4669
Yasuda, Masahiko
Xu, Huaigeng http://orcid.org/0000-0002-4415-1287
Noda, Takeshi
Komano, Jun http://orcid.org/0000-0003-4610-1950
Sakurai, Hidetoshi
Inukai, Naoto http://orcid.org/0000-0003-2331-3723
Hotta, Akitsu http://orcid.org/0000-0002-2619-7441
-
Funding
Funding for this research was provided by:
Takeda Pharmaceutical Company (T-CiRA Joint Program)
Japan Agency for Medical Research and Development (the Core Center for iPS Cell Research)
MEXT | Japan Society for the Promotion of Science (Grant-in-Aid for Young Scientists B)
- License Information
-
More Information
Article History
Received: 13 March 2019
Accepted: 10 February 2020
First Online: 13 March 2020
Competing interests
: P.G. and A.H. are inventors on a filed patent (PCT/JP2019/027708) based on the delivery system, virus-like particle, production, and use for genome editing described here. Y.M., H.H., and N.I. are employees of Takeda Pharmaceutical Company. A.H. is a principle investigator (without salary) of the T-CiRA program funded by Takeda Pharmaceutical Company. All other authors declare no competing interests.
